PRESS RELEASE

Vivlion GmbH signs worldwide license agreement with ERS Genomics for CRISPR/Cas9 patent portfolio

HIGHLIGHTED IN THE SPINOFF PRIZE

Vivlion® is selected as one of the most exciting science-based companies  bred out of academia and is on the list as "one to watch" in the new Spinoff Prize competition launched by Nature and Merck KGaA Darmsatdt, Germany.

NEWS & PRESS

GIT Laborportal features 3Cs technology

FEATURED CITATION

Circular synthesized CRISPR/Cas gRNAs for functional interrogations in the coding and noncoding genome. Wegner M, Diehl V, et al.

Elife 2019, 8: e42549. doi: 10.7554/eLife.42549.

NEWS & PRESS

Goethe University Frankfurt am Main announces spin-off of Vivlion GmbH.

FEATURED PRESENTATION

Vivlion CSO Manuel Kaulich giving a LabRoots presentation.